| Literature DB >> 28530676 |
Hao Lu1, Maria C Rondón Galeano2, Elisabeth Ott3, Geraldine Kaeslin2, P Jaya Kausalya1, Carina Kramer3, Nadina Ortiz-Brüchle4, Nadescha Hilger4, Vicki Metzis2, Milan Hiersche5, Shang Yew Tay1, Robert Tunningley6, Shubha Vij1, Andrew D Courtney2, Belinda Whittle6, Elke Wühl7, Udo Vester8, Björn Hartleben9, Steffen Neuber5, Valeska Frank5, Melissa H Little2, Daniel Epting3, Peter Papathanasiou6, Andrew C Perkins2,10, Graham D Wright11, Walter Hunziker1,12,13, Heon Yung Gee14,15, Edgar A Otto16, Klaus Zerres4, Friedhelm Hildebrandt14, Sudipto Roy1,17,18, Carol Wicking2, Carsten Bergmann3,4,5.
Abstract
Autosomal recessive polycystic kidney disease (ARPKD), usually considered to be a genetically homogeneous disease caused by mutations in PKHD1, has been associated with ciliary dysfunction. Here, we describe mutations in DZIP1L, which encodes DAZ interacting protein 1-like, in patients with ARPKD. We further validated these findings through loss-of-function studies in mice and zebrafish. DZIP1L localizes to centrioles and to the distal ends of basal bodies, and interacts with septin2, a protein implicated in maintenance of the periciliary diffusion barrier at the ciliary transition zone. In agreement with a defect in the diffusion barrier, we found that the ciliary-membrane translocation of the PKD proteins polycystin-1 and polycystin-2 is compromised in DZIP1L-mutant cells. Together, these data provide what is, to our knowledge, the first conclusive evidence that ARPKD is not a homogeneous disorder and further establish DZIP1L as a second gene involved in ARPKD pathogenesis.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28530676 PMCID: PMC5687889 DOI: 10.1038/ng.3871
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330